Journals / Marmara Pharmaceutical Journal / 2017 / Cilt: 21 - Sayı: 4

Synthesis and evaluation of novel 2-[(1,2,4-triazol-3-yl)thio]acetamide derivatives as potential serum paraoxonase-1 (PON1) activators

Pages
967–977
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Compounds 5b, 5c, 5f and 5h bearing 5-nitrothiazole, benzothiazole, 6-ethoxybenzothiazole and 6-florobenzothiazole moieties could be considered to proceed in vivo investigations which is a further stage for a drug candidate.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coronary artery disease and low-density lipoprotein (LDL) levels in the blood have long been known to be associated with peripheral vascular diseases.
📊
Key Findings & Data:Paraoxonase-1 (PON1) enzyme is related to serum levels of high-density lipoprotein (HDL) and protects LDL from oxidation which may result in development of microvascular disease in diabetes.
💡
Conclusion & Impact:Compounds 5b, 5c, 5f and 5h bearing 5-nitrothiazole, benzothiazole, 6-ethoxybenzothiazole and 6-florobenzothiazole moieties could be considered to proceed in vivo investigations which is a further stage for a drug candidate.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Coronary artery disease and low-density lipoprotein (LDL) levels in the blood have long been known to be associated with peripheral vascular diseases. Paraoxonase-1 (PON1) enzyme is related to serum levels of high-density lipoprotein (HDL) and protects LDL from oxidation which may result in development of microvascular disease in diabetes. The enzyme has a major role in the prevention of atherosclerosis besides antioxidant properties. Additionally, PON1 is important in the detoxification of organophosphate insecticides from the body. In this study, we aimed to synthesize highly active new compounds which can be a drug candidate and evaluate their effects on PON1 activity. Nine novel triazole compounds bearing thioacetamide moiety (5a-i) were synthesized and their in vitro PON1 activity was investigated. The PON1 enzyme was purified from human serum using ammonium sulfate precipitation method. Also, it was further purified using Sepharose 4B-L-tyrosine1-naphthylamine affinity chromatography. Among the synthesized triazole compounds, 5b, 5c, 5f and 5h have been determined to increase PON1 activity, remarkably. Compounds 5b, 5c, 5f and 5h bearing 5-nitrothiazole, benzothiazole, 6-ethoxybenzothiazole and 6-florobenzothiazole moieties could be considered to proceed in vivo investigations which is a further stage for a drug candidate.

🔖

Cite This Article

YURTTAŞ, L., KÜÇÜKOĞLU, K., NADAROĞLU, H., KAPLANCIKLI, Z. A. (2017). Synthesis and evaluation of novel 2-[(1,2,4-triazol-3-yl)thio]acetamide derivatives as potential serum paraoxonase-1 (PON1) activators. Marmara Pharmaceutical Journal, Cilt: 21 - Sayı: 4, 967–977. https://ajindex.com/articles/283710

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Laemmli UK. Cleavage of the structural proteins during the assembly of the head of bacteriophage T4. Nature1970; 227: 680-5. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
  2. Demir N, Nadaroğlu H, Demir Y. Purification of human serum paraoxonase and effect of acetyl salicylic acid on paraoxonase activity. Pharm Biol 2008; 46: 393-9.
  3. Demir Y, Nadaroğlu H, Demir N. Effect of glimepride on paraoxonase activity. Pharm Biol 2006; 44: 396-9.
  4. Renault F, Chabrière E, Andrieu J, Dublet B, Massona P, Rochua D. Tandem purification of two HDL-associated partner proteins in human plasma, paraoxonase (PON1) and phosphate binding protein (HPBP) using hydroxy apatite chromatography. J Chromatogr B 2006; 836: 15-21.
  5. Gobis K, Foks H, Bojanowski K, Augustynowicz-Kopeć E, Napiórkowska A. Synthesis of novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their evaluation for tuberculostatic activity. Bioorg Med Chem; 2012; 20: 137-44.
  6. De Benneville PL, Connor R. The hydrogenation of coumarin and related compounds. J Am Chem Soc 1940; 62: 283-7. Ekmekçi H. Paraoksonaz. Cerrahpaşa Tıp Derg 2004; 35: 7882. Turan-Zitouni G, Kaplancıklı ZA, Yıldız MT, Chevallet P, Kaya D. Synthesis and antimicrobial activity of 4-phenyl/ cyclohexyl-5-(1-phenoxyethyl)-3-[N-(2-thiazolyl)acetamido] thio-4H-1,2,4-triazole derivatives. Eur J Med Chem 2005; 40: 607-13.
  7. Gill RK, Rawal RK, Bariwal J. Recent advances in the chemistry and biology of benzothiazoles. Arch Pharm Chem Life Sci 2015; 348: 155-78.
  8. Leoni A, Locatelli A, Morigi R, Rambaldi M. Novel thiazole derivatives: a patent review (2008 – 2012; Part 1). Expert Opin Ther Pat 2014; 24: 201-16.
  9. Al-Masoudi IA, Al-Soud YA, Al-Salihi NJ, Al-Masoudi NA. 1,2,4-Triazoles: Synthetic approaches and pharmacological importance. (Review). Chem Het Comp 2006; 42: 1377-1403.
  10. Kumar SS, Kavitha HP. Synthesis and biological applications of triazole derivatives – A review. Mini Rev Org Chem 2013; 10: 40-65.
  11. Carreon-Torres E, Rendon-Sauer K, Monter-Garrido M, Toledo-Ibelles P, Gamboa R, Menjivar M, Lopez-Marure R, Luc G, Fievet C, Cruz D, Vargas-Alarcon G, and Perez-Mendez O. Rosiglitazone modifies HDL structure and increases HDLapo AI synthesis and catabolicrates. Clin Chim Acta 2009; 401: 37-41. van Wijk J, Coll B, Cabezas MC, Koning E, Camps J, Mackness B, Joven J. Rosiglitazone modulates fasting and post-prandial